The ExecFactor® initiative will offer digital solutions and business workflow design services DETROIT–(BUSINESS WIRE)–Leading middle-market…
Headlined by GTM Roundtable with ZoomInfo CEO Henry Schuck and Executives from Snowflake and Bain,…
B2b and b2c markets include AV, gaming and home automation NEW YORK, September 6, 2023 – Technology public…
LA JOLLA, CA, Sept. 06, 2023 (GLOBE NEWSWIRE) — GRI Bio, Inc. (NASDAQ: GRI) (“GRI…
LA JOLLA, CA, Sept. 06, 2023 (GLOBE NEWSWIRE) — GRI Bio, Inc. (NASDAQ: GRI) (“GRI…
SOLANA BEACH, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical…
SOLANA BEACH, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical…
SAN DIEGO, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology…
SAN DIEGO, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology…
VANCOUVER, British Columbia, Sept. 06, 2023 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or…
VANCOUVER, British Columbia, Sept. 06, 2023 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or…
HAMILTON, BERMUDA , Sept. 06, 2023 (GLOBE NEWSWIRE) — Altamira Therapeutics Ltd. (“Altamira” or the…
HAMILTON, BERMUDA , Sept. 06, 2023 (GLOBE NEWSWIRE) — Altamira Therapeutics Ltd. (“Altamira” or the…
– Lead program, GT-2108 for the treatment of moderate-to-severe ulcerative colitis advancing toward completion of…
– Lead program, GT-2108 for the treatment of moderate-to-severe ulcerative colitis advancing toward completion of…
NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
WALTHAM, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a…
WALTHAM, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a…
TORONTO and HAIFA, Israel, Sept. 06, 2023 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX)…